SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   FORM 10-QSB

(Mark One)
 X   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
---  EXCHANGE ACT OF 1934


For the quarterly period ended               September 30, 2002
                               -------------------------------------------------
     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
---  EXCHANGE ACT OF 1934

For the transition period  from                         to
                                -----------------------    ---------------------

Commission file number                         0-16286
                       ---------------------------------------------------------

                              MEDPLUS CORPORATION
--------------------------------------------------------------------------------
               (Exact name of registrant as specified in its charter)

Delaware                                                 95-4082020
--------------------------------------------------------------------------------
(State or other jurisdiction of             (IRS Employer identification number)
 incorporation or organization)

6302 Mesedge Drive, Colorado Springs, Colorado             80919
--------------------------------------------------------------------------------
(address of principle executive offices)                 (Zip Code)

                                  719-447-8856
--------------------------------------------------------------------------------
               (Registrants telephone number, including area code)

121 East Pikes Peak,  Ste. 355, Colorado Springs, Colorado      80903
--------------------------------------------------------------------------------
Former name, former address and former fiscal year, (if changed since last
report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.   Yes   X   No
                                          ---     ---

                       APPLICABLE ONLY TO ISSUERS INVOLVED
                        IN BANKRUPTCY PROCEEDINGS DURING
                            THE PRECEDING FIVE YEARS

Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by section 13 or 15 (d) of the Securities Exchange
Act of 1934 subsequent to the distribution requirements under a plan confirmed
by a court.  Yes      No
                 ---     ---

                      APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
  Class                                        Outstanding at October 28, 2002
--------------------------------------------------------------------------------
  Common Stock, Par-Value
--------------------------------------------------------------------------------
  $.001 per share                              32,338,958
--------------------------------------------------------------------------------


<PAGE>
                               MEDPLUS CORPORATION

                              REPORT ON FORM 10-QSB


                                TABLE OF CONTENTS


PART I                                                         PAGE NUMBER
------                                                         -----------

ITEM 1. - FINANCIAL INFORMATION

          Balance Sheets at September 30, 2002 . . . . . . . . . .    3

          Statements of Operations for the
            Six Months Ended September 30, 2002
            and September 30, 2001 and for Three
            Months Ended September 30, 2002
            and September 30, 2001 . . . . . . . . . . . . . . . .    4

          Statements of Cash Flows for the
            Six Months Ended September 30, 2002
            and September 30, 2001 . . . . . . . . . . . . . . . .    4

       Notes to Financial Statements . . . . . . . . . . . . . . .    5

ITEM 2. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE
          FINANCIAL CONDITION AND RESULTS OF
          OPERATIONS . . . . . . . . . . . . . . . . . . . . . . .    6

PART II
-------

          Other Information. . . . . . . . . . . . . . . . . . . .    6

          Signature Page . . . . . . . . . . . . . . . . . . . . .    6



                                        2
<PAGE>
<TABLE>
<CAPTION>
                                     PART I
                         ITEM 1.  FINANCIAL INFORMATION
                               MEDPLUS CORPORATION


BALANCE SHEETS

ASSETS                                                September 30, 2002
                                                         (Unaudited)
<S>                                                  <C>
CURRENT ASSETS:
Cash and cash equivalents                            $               947
Note receivable                                                   35,000
                                                     --------------------

Total current assets                                              35,947
                                                     --------------------

PROPERTY:
Office Equipment                                                       0
Furniture and Fixtures                                                 0
                                                     --------------------

Total                                                                  0
Less accumulated depreciation                                          0
                                                     --------------------

TOTAL ASSETS                                         $            35,947
                                                     ====================

LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
Accrued expenses                                     $           113,885
Notes payable -Related parties                                   116,741
Accrued Payroll Taxes                                             94,500
Shareholder Loans                                                  4,929
                                                     --------------------

Total liabilities                                                330,055
                                                     --------------------


SHAREHOLDERS' EQUITY:
Preferred stock, $.001 par value;
authorized 2,000,000 shares; no shares outstanding
Common stock, $.001 par value;
  authorized, 100,000,000 shares;
  32,338,958 issued and outstanding                               32,339
Additional paid in capital                                    10,673,147
Accumulated deficit                                          (10,999,594)
                                                     --------------------

Net shareholders' equity (deficit)                              (294,108)
                                                     --------------------

TOTAL                                                $            35,947
                                                     ====================
</TABLE>

                 See accompanying notes to financial statements


                                        3
<PAGE>
<TABLE>
<CAPTION>
                              MEDPLUS CORPORATION
                      STATEMENTS OF OPERATIONS (UNAUDITED)

                                    Three Month Period         Six Month Period
                                    Ended September 30,       Ended September 30,
                                 ------------------------  ------------------------
                                    2001         2002          2001        2002
                                 -----------  -----------  -----------  -----------
<S>                              <C>          <C>          <C>          <C>
REVENUES:                        $         0  $        0   $         0  $        0
---------

EXPENSES:
---------
Contract Services                $         0  $    2,000   $         0  $    2,000
Other Expenses                             0       4,750             0       4,750
Professional Fees                          0         697             0         697
Total expenses                             0       7,447             0       7,447

Loss from Operations             $            $   (7,447)            0      (7,447)

OTHER INCOME (Expenses)
-----------------------
Debt Forgiveness                              $  118,670                $  118,670

Net Income/loss from operation             0  $  111,223             0  $  111,223

Loss  / Income Per Share                 nil         nil           nil         nil
                                 ===========  ===========  ===========  ===========
Weighted average number of
  common shares outstanding       21,904,000  29,088,958    21,904,000  29,088,958
</TABLE>

<TABLE>
<CAPTION>
                      STATEMENTS OF CASH FLOWS (UNAUDITED)
                                                        Six Month Period
                                                      Ended September 30,
                                                   -------------------------
                                                      2001          2002
                                                   -----------  ------------
<S>                                                <C>          <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)                                  $        0   $   111,223
Changes in operating assets and liabilities
     Other Current Assets                             (50,000)
     Accounts payable                                (103,962)     (118,670)
     Other Liabilities                                                8,394
                                                                ------------
     Total Adjustments                               (153,962)     (110,276)
                                                                ------------
Net cash provided (used) by operating activities   $ (153,962)  $       947
CASH FLOWS FROM INVESTING ACTIVITIES:
     Fixed Assets                                           -             -
Net cash provided (used) by investing activities            -             -
CASH FLOWS FROM FINANCING ACTIVITIES:
     Note Payable - Related Party
     Note Payable
     Stock Issued for Debt Reduction                  154,480
Net Cash Provided for financing activities            154,480             -
Increase (decrease) in cash                               518           947
Cash  beginning of period                                   0             -

Cash at end of period                              $      518   $       947
                                                   ===========  ============
</TABLE>

                 See accompanying notes to financial statements


                                        4
<PAGE>
                               MEDPLUS CORPORATION
                    NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

1.   GOING  CONCERN  The  Company's  financial  statements  are  prepared  using
     --------------
     generally  accepted  accounting  principles  applicable to a going concern,
     which contemplates the realization of assets and liquidation of liabilities
     in  the  normal  course  of  business.  However,  the Company does not have
     significant  cash or other material assets, nor does it have an established
     source  of revenues sufficient to cover its operating costs and to allow it
     to continue as a going concern. These factors raise substantial doubt about
     the  Company's  ability  to  continue  as  a  going  concern. The Company's
     continuation  as  a going concern is dependent upon its ability to generate
     sufficient  cash  to  meet  its  obligations  on  a timely basis, to obtain
     financing  as  may  be  required,  and  ultimately  to  attain  successful
     operations. Management is continuing its efforts to obtain additional funds
     needed  for  the  successful  operation  of  the  Company.

2.   BASIS  OF PRESENTATION  The  accompanying  unaudited consolidated financial
     ----------------------
     statements  of  MEDPLUS  CORPORATION contain all adjustments (consisting of
     only  normal recurring adjustments) which, in the opinion of management are
     necessary to present fairly the financial position of the Company as of the
     periods  ended  September  30,  2002 and March 31, 2002, and the results of
     operations  and  its  cash  flows for the three and six month periods ended
     September 30, 2001 and September 30, 2002. Certain information and footnote
     disclosures  normally  included in financial statements have been condensed
     or omitted pursuant to rules and regulations of the Securities and Exchange
     Commission,  although  the  registrant believes that the disclosures in the
     consolidated  financial  statements  are  adequate  to make the information
     presented  not  misleading.

     Income  Taxes  Deferred  income  taxes  arise  from  temporary  differences
     -------------
     resulting  from  the  Company's  subsidiary  utilizing  the  cash  basis of
     accounting  for  tax purposes and the accrual basis for financial reporting
     purposes.  Deferred  taxes  are  classified  as  current  or  non-current,
     depending on the classification of the assets and liabilities to which they
     relate. Deferred taxes arising from timing differences that are not related
     to an asset or liability are classified as current or non-current depending
     on the periods in which the timing differences are expected to reverse. The
     Company's  previous  principal  temporary differences relate to revenue and
     expenses  accrued  for  financial  purposes,  which  are  not  taxable  for
     financial  reporting purposes. The Company's material temporary differences
     consist  of  bad  debt expense recorded in the financial statements that is
     not deductible for tax purposes and differences in the depreciation expense
     calculated  for  financial  statement  purposes  and  tax  purposes

     As  of  March 31, 2002, the Company has net operating loss carryforwards of
     approximately  $8,632,000 which started expiring in fiscal year 2000. As of
     March  31,  2002,  the Company has recorded a valuation allowance to reduce
     existing  deferred  tax  assets  since  the  assets  are  not  likely to be
     realized.

3.   COMPUTATION OF NET LOSS PER  SHARE  Net  loss  per  share  is  computed  by
     ----------------------------------
     dividing  net loss by the weighted average number of shares of common stock
     outstanding.  Options  and  warrants  are not included because their effect
     would  be  antidilutive.

4.   NOTES  PAYABLE  TO  RELATED  PARTIES  Notes payable to related parties, all
     ------------------------------------
     of  which are considered to be current liabilities by their terms or due to
     default,  consist  of  the  following  at  September  30,  2002:

     Unsecured  note  payable  to  a  shareholder  of  the Company, non-interest
     bearing,  due in equal monthly installments of $2,000 from May 1996 through
     April  1997  with a final installment of $123,288 payable on May 1997. This
     note is recorded net of unamortized discount of $5,074 at March 31, 1997 to
     reflect  an  effective  interest  rate of 18%. Payments on this note are in
     default.
                                                                        $116,741
     Unsecured  note payable to shareholder of the Company bearing interest at a
     range  between  10% to 17% depending on shareholder's credit card rate. The
     note  is  payable  on  demand  and  in  default.
                                                                          $4,929
                                                       Total            $121,670


                                        5
<PAGE>
                ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                  ---------------------------------------------

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------
At  September 30, 2002 the Company had working capital of ($294,108) compared to
working  capital  of  ($446,831)  at  March  31,  2002.  The increase of working
capital  primarily due to the Company settling a debt obligation.  The Company's
current  liabilities  are  higher than its assets due primarily to borrowings in
the  form  of  promissory  notes  from  shareholders  of the Company and related
parties  along  with  accrued  payables  and  expenses.

The  Company's  liquidity  position  is  severely strained.  Liquidity needs are
currently  being  met from short-term borrowing in the form of promissory notes.
Because  the  Company  has  not  achieved  positive cash flow from its operating
activities,  the  company  ceased  normal operations in May 1998.  The Company's
ability to continue operations is dependent upon its ability to raise additional
equity and/or debt financing.  This and other factors raise substantial doubt as
to  the  Company's  ability to continue as a going concern.  Management believes
the  Company  needs approximately $ 250,000 in equity or debt financing in order
to  sustain  operations  for  the  next twelve months following the period ended
September 30, 2002.  Although the Company is actively engaged in activities with
intent  to  raise  equity  and/or  debt financing in order to meet its long-term
liquidity  needs,  there  can  be  no assurance that the Company will be able to
consummate  the  transaction and/or raise the additional financing necessary for
continuing  operations

RESULTS  OF  OPERATIONS
-----------------------
There  was no revenue derived from the sale of products from the Company for the
six  month  period  ended  September  30, 2002 or for the six month period ended
September  30,  2001. This attributable to the decline in patient financing with
no  employees  to  support  the  financing  activities.
There  were  no  General  and Administrative expenses for operations for the six
month  period  ended  September  30,  2002.  There  were  no Sales and Marketing
expenses  for  operations  for  the  six-month  period  ended September 30, 2002

PART II     OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS                                        None
        -----------------

ITEM 2. CHANGES IN SECURITIES                                    None
        ---------------------

ITEM 3. DEFAULTS UPON SENIOR SECURITIES                          None
        -------------------------------

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDER     None
        ----------------------------------------------------

ITEM 5. OTHER INFORMATION
        -----------------
OFFER  AND COMPRIMISE ACCEPTED - On August 7, 2001, the Internal Revenue Service
accepted  an offer of $ 94,500 to settle outstanding payroll tax liabilities and
release liens associated with payroll taxes from 1996 through 1999. The offer is
due  to be paid in January 2002. The accrued payroll taxes have been adjusted in
these  financial  statements  to  reflect  this settlement. This remains unpaid.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
        --------------------------------

     a.  Exhibits                    b.  Reports on Form 8-k
         None                            None

Signatures    Pursuant to the requirements of the Securities and Exchange Act of
----------
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

                                                 MEDPLUS CORPORATION

Date:  October 28, 2002                          \By\Tim C. DeHerrera
                                                 --------------------
                                                 Tim C. DeHerrera / Director


                                        6
<PAGE>